CorMedix Management
Management criteria checks 1/4
CorMedix's CEO ist Joe Todisco , ernannt in May 2022, hat eine Amtszeit von 1.58 Jahren. Die jährliche Gesamtvergütung beträgt $2.90M , bestehend aus 13% Gehalt und 87% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.21% der Aktien des Unternehmens, im Wert von $381.61K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.6 Jahre bzw. 1.8 Jahre.
Key information
Joe Todisco
Chief executive officer
US$2.5m
Total compensation
| CEO salary percentage | 25.1% |
| CEO tenure | 1.9yrs |
| CEO ownership | 0.3% |
| Management average tenure | 1.9yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely
Nov 02
Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation
Jul 31CorMedix (NASDAQ:CRMD) Is In A Good Position To Deliver On Growth Plans
Feb 25FDA again rejects CorMedix's application for lead candidate DefenCath, shares sink ~60%
Aug 08Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation
Jul 16We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely
Mar 01Here's Why We're Not Too Worried About CorMedix's (NASDAQ:CRMD) Cash Burn Situation
Sep 09CorMedix Inc.'s (NASDAQ:CRMD) Intrinsic Value Is Potentially 58% Above Its Share Price
Feb 11We're Hopeful That CorMedix (NYSEMKT:CRMD) Will Use Its Cash Wisely
Jan 04CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$617k | -US$46m |
| Sep 30 2023 | n/a | n/a | -US$40m |
| Jun 30 2023 | n/a | n/a | -US$37m |
| Mar 31 2023 | n/a | n/a | -US$33m |
| Dec 31 2022 | US$3m | US$378k | -US$30m |
Vergütung im Vergleich zum Markt: JoeDie Gesamtvergütung ($USD2.90M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD1.53M).
Entschädigung vs. Einkommen: JoeDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
CEO
Joe Todisco (46 yo)
1.9yrs
Tenure
US$2,459,432
Compensation
Mr. Joseph Todisco, also known as Joe, MBA, serves as Chief Executive Officer of CorMedix Inc. since May 10, 2022. He has served as Director of CorMedix Inc. since March 18, 2022 and served as its Independ...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 1.9yrs | US$2.46m | 0.27% $ 615.8k | |
| Executive VP & CFO | 3.9yrs | US$1.03m | 0.019% $ 43.1k | |
| Executive VP & Chief Commercial Officer | 4.1yrs | US$1.26m | 0.024% $ 53.7k | |
| Executive VP and Chief Clinical Strategy & Operations Officer | less than a year | US$844.81k | 0.014% $ 32.6k | |
| Executive VP | less than a year | no data | no data | |
| Senior VP & Head of Global Quality | 1.9yrs | no data | no data | |
| Senior VP & Head of Technical Operations | 1.3yrs | no data | no data |
1.9yrs
Average Tenure
43.5yo
Average Age
Erfahrenes Management: CRMDDas Führungsteam des Unternehmens gilt nicht als erfahren ( 1.6 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2.1yrs | US$2.46m | 0.27% $ 615.8k | |
| Independent Chairman of the Board | 8yrs | US$191.96k | 0.33% $ 747.7k | |
| Independent Director | 5.1yrs | US$141.42k | 0.028% $ 63.0k | |
| Independent Director | 8.7yrs | US$147.42k | 0.097% $ 220.9k | |
| Independent Director | 6.8yrs | US$162.42k | 0.14% $ 320.1k | |
| Independent Director | 3.4yrs | US$141.42k | 0% $ 0 | |
| Member of Scientific Advisor Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 2yrs | no data | no data | |
| Member of Scientific Advisory Board | 2yrs | no data | no data | |
| Member of Scientific Advisory Board | 2yrs | no data | no data | |
| Member of Scientific Advisory Board | 2yrs | no data | no data | |
| Member of Scientific Advisory Board | 2yrs | no data | no data |
2.1yrs
Average Tenure
67yo
Average Age
Erfahrener Vorstand: CRMDDie Vorstandsmitglieder gelten nicht als erfahren ( 1.8 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.